Rare opportunity to acquire i.o. extracts, a turnkey Arizona cannabis extraction and manufacturing lab located in Tucson, Arizona. The company operates from a fully built-out 10,001 sq ft facility with significant installed extraction, distillation, processing, manufacturing, and lab infrastructure.

This is an active operating business, not a simple equipment liquidation. i.o. extracts has historically generated over $5M in annual revenue, including $5,159,319 in 2023 and $5,209,582 in 2024. Buyer-safe adjusted trailing revenue is approximately $3,117,971 after excluding a known uncollectable receivable/revenue item. Buyer-safe adjusted SDE is approximately $775,000, with adjusted EBITDA of approximately $582,454.

Asking price is $5,000,000. Inventory is included in the sale. Inventory valuation ranges from approximately $690,117 conservative bulk wholesale value to approximately $1,271,439 standard wholesale/internal value, with potential branded retail value estimated between $3,688,996 and $5,835,107 depending on pricing, brand strategy, and sales channel.

The facility is leased under a 10-year lease signed in 2022 with renewal options. The facility lease is transferable subject to standard approvals. The business also operates under a leased cannabis license structure, and the cannabis license lease is transferable subject to standard approvals and final documentation.

Equipment/buildout is estimated at over $3,000,000 in original/replacement value. Major assets include extraction systems, distillation equipment, processing equipment, lab infrastructure, production areas, and related cannabis manufacturing equipment. Detailed equipment and inventory schedules are available during due diligence.

Cash on hand, accounts receivable, Bitcoin/crypto assets, personal assets of the seller, and any specifically excluded assets are not included in the sale unless separately negotiated.

Arizona cannabis remains a competitive but established market where efficient, well-equipped operators have an advantage. Building a comparable compliant extraction/manufacturing facility from scratch would be expensive, time-consuming, and difficult. This acquisition provides a buyer with immediate infrastructure, equipment, license/lease structure, production history, customer relationships, and inventory already in place.

Growth opportunities include increasing toll processing volume, expanding white-label manufacturing, adding new licensed operator relationships, improving sales outreach, increasing facility utilization, expanding product categories, leveraging existing equipment/buildout, and using the lab as a strategic Arizona production hub.

Owner has received a recent cancer diagnosis and is pursuing a strategic life transition. The business remains active, operational, and profitable. Seller is willing to provide meaningful transition support, consulting, customer/vendor introductions, operational training, or potentially retain minority equity to help ensure continued success under new ownership.

This opportunity may be especially attractive to an existing cannabis operator, MSO, brand, new to the industry or licensed group seeking immediate manufacturing capacity without the delay, capital expense, permitting, staffing, equipment sourcing, and operational risk of building a comparable lab from scratch.


Seller may consider a small seller-financed portion for a qualified buyer with a strong down payment and appropriate terms. Qualified buyers should have proof of funds or financing capability. NDA required before release of detailed financials, equipment schedules, customer information, lease/license documents, or inventory details.